Literature DB >> 35774909

Exploring the End-of-Life Experiences of Advanced Cancer Patients from India.

Maria Wajid1, Eslavath Rajkumar1, J Romate1.   

Abstract

Objective: Paying attention to the socio-cultural characteristics of advanced cancer patients as they pass through the final stages of life can help healthcare professionals and mental health professionals assess the end-of-life experiences of terminally ill patients better. A comprehensive study of this population in the Indian context is helpful to devise individualized end-of-life care that aligns with their preferences and focuses on their comfort. Method: The dataset comprised information-rich cases of 10 advanced cancer patients from Bangalore, India, selected using the purposive sampling method. The semi-structured interviews with the participants were audio-recorded, transcribed, and translated. Identification of patterns and commonalities in the dataset helped generate codes. The codes were used to narrow down to overarching themes.
Results: The standout themes were outlook on life, unfulfilled goals, end-of-life expectations, and death anxieties and attitudes to impending death. Significance of
Results: The study highlights the psychosocial and cultural needs of the patients in end-of-life care. How advanced cancer patients long for psychological care from mental health professionals and empathy from their loved ones. This study argues for renewed attention on the socio-cultural characteristics of terminally ill patients to enhance individualized care through culturally-competent interventions.

Entities:  

Keywords:  Better Care; Dying and Death; End of Life; India; Terminal Ill Cancer Patients

Year:  2022        PMID: 35774909      PMCID: PMC9239383     

Source DB:  PubMed          Journal:  Health Psychol Res        ISSN: 2420-8124


  34 in total

1.  Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine.

Authors:  S D Block
Journal:  Ann Intern Med       Date:  2000-02-01       Impact factor: 25.391

Review 2.  The cancer patient with pain: psychiatric complications and their management.

Authors:  M J Massie; J C Holland
Journal:  J Pain Symptom Manage       Date:  1992-02       Impact factor: 3.612

3.  [The meaning of a good death for terminally ill cancer patients in Taiwan].

Authors:  C S Chao
Journal:  Hu Li Za Zhi       Date:  1997-02

4.  Existential loneliness in a palliative home care setting.

Authors:  Lisa Sand; Peter Strang
Journal:  J Palliat Med       Date:  2006-12       Impact factor: 2.947

Review 5.  Death anxiety in older adults: a quantitative review.

Authors:  B V Fortner; R A Neimeyer
Journal:  Death Stud       Date:  1999 Jul-Aug

6.  Depression and anxiety disorders in palliative cancer care.

Authors:  Keith G Wilson; Harvey Max Chochinov; Merika Graham Skirko; Pierre Allard; Srini Chary; Pierre R Gagnon; Karen Macmillan; Marina De Luca; Fiona O'Shea; David Kuhl; Robin L Fainsinger; Jennifer J Clinch
Journal:  J Pain Symptom Manage       Date:  2007-02       Impact factor: 3.612

7.  Denial of impending death: a discourse analysis of the palliative care literature.

Authors:  Camilla Zimmermann
Journal:  Soc Sci Med       Date:  2004-10       Impact factor: 4.634

8.  The attitudes of cancer patients and their families toward the disclosure of terminal illness.

Authors:  Young Ho Yun; Chang Geol Lee; Si-young Kim; Sang-wook Lee; Dae Seog Heo; Jun Suk Kim; Keun Seok Lee; Young Seon Hong; Jung Suk Lee; Chang Hoon You
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

Review 9.  Death anxiety: an analysis of an evolving concept.

Authors:  Rebecca Helen Lehto; Karen Farchaus Stein
Journal:  Res Theory Nurs Pract       Date:  2009       Impact factor: 0.688

10.  Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires.

Authors:  P Hopwood; A Howell; P Maguire
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.